2,000
Participants
Start Date
October 15, 2021
Primary Completion Date
June 15, 2028
Study Completion Date
December 30, 2029
LungGuard
The LUNGguard is an FDA cleared and is a CE-marked medical device intended to be used for the static hypothermic preservation of lungs during transportation and eventual transplantation into a recipient using cold storage solutions indicated for use with the lungs. The intended organ storage time for the LUNGguard is up to 8 hours.
BAROGuard
"The BAROguard (the System) is ultraportable hypothermic preservation and transport system intended for use with donor lungs. BAROguard is a legally marketed, FDA cleared medical device in the United States. The intended organ storage time for BAROguard™ is up to 8 hours."
University Hospitals Leuven, Leuven
Montefiore Hospital, The Bronx
University of Pittsburgh Medical Center, Pittsburgh
Temple University Hospital, Philadelphia
Johns Hopkins University, Baltimore
University of Virginia, Charlottesville
Duke Lung Transplant Clinic, Durham
Mayo Clinic Jacksonville, Jacksonville
Baylor Scott & White Research Institute, Dallas
The University of Texas Southwestern Medical Center, Dallas
Houston Methodist Hospital, Houston
St. Joseph's Hospital and Medical Center, Phoenix
University of California, San Francisco, San Francisco
Stanford Medicine, Stanford
Massachusetts General Hospital, Boston
Lead Sponsor
Paragonix Technologies
INDUSTRY